Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry

Margalida Calafat Sard  1     Miriam Mañosa  2     Elena Ricart  3     Pilar Nos Mateu  4     Eva Iglesias  5     Isabel Vera  6     Antonio López-San Román  7     Jordi Guardiola     Carlos Taxonera     Miguel Mínguez     Mariló Martin-Arranz     Luisa de Castro     Sabino Riestra     Montserrat Rivero     Esther García-Planella     Xavier Calvet     Santiago García-López     Montserrat Andre    
1 Hospital Universitari Germans Trias i Pujol,Barcelona,Spain
2 Hospital Universitari Germans Trias i Pujol,Badalona,Spain
3 Hospital Clinic,Barcelona,Spain
4 Hospital La Fe,Valencia,Spain
5 Hospital Universitario Reina Sofía,Córdoba,Spain
6 Hospital Universitario Puerta de Hierro Majadahonda,Majadahonda,Spain
7 Hospital Universitario Ramon

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing